首页 > 最新文献

American Journal of Obstetrics & Gynecology Mfm最新文献

英文 中文
Placental cytogenetic testing for confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening results. 无细胞DNA筛查结果不一致后,限制性胎盘嵌合体的胎盘细胞遗传学检测和产科结局。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-09 DOI: 10.1016/j.ajogmf.2025.101887
Yvette Raymond, Shavi Fernando, Melody Menezes, Ben W Mol, Emma Brown, Kirsten Arnold, Daniel L Rolnik

Background: A false-positive cell-free DNA prenatal screening result may arise from confined placental mosaicism, however, the frequency and obstetrical ramifications of such cases are poorly understood.

Objective: This study aimed to assess the prevalence of confined placental mosaicism among pregnancies with false-positive cell-free DNA results and the associated obstetrical outcomes.

Study design: This was a prospective, matched-cohort study with a 1:2 ratio of cases with false-positive cell-free DNA results and controls with low-risk cell-free DNA results that were matched by maternal age and body mass index. Participants were recruited between November 2022 and March 2025 at Monash Health and Monash Ultrasound for Women in Melbourne, Australia. Cytogenetic testing was conducted on 4 biopsies per placenta to investigate confined placental mosaicism. The cases and matched controls were compared using trio matching identifiers as random effect in conditional logistic regression and linear mixed-effects modelling.

Results: A total of 60 cases with false-positive cell-free DNA results were matched with 120 controls. Confined placental mosaicism was observed in 20 of the 60 cases (33.3%) and in none of the controls. The prevalence of confined placental mosaicism was highest among those with rare autosomal trisomy (57.9%; 11/19) and monosomy X (75.5%; 3/4) results. Confined placental mosaicism was also observed following common autosomal trisomy results (21.4%; 3/14) and subchromosomal copy number variants (15.8%; 3/19). The median birth weight percentile was significantly lower among instances of confirmed confined placental mosaicism (20.1; interquartile range, 9.9-48.5) than among matched controls (43.5; interquartile range, 17.1-66.1; P=.049); however, there were no statistically significant increases in small-for-gestational-age neonates or other adverse pregnancy outcomes.

Conclusion: Confined placental mosaicism is a frequent contributor to false-positive cell-free DNA results, most often for monosomy X and rare autosomal trisomy results. Although the birth weight median percentiles were lower, the outcomes of cell-free DNA-detected confined placental mosaicism in this average-risk cohort were predominantly favorable. VIDEO ABSTRACT.

背景:无细胞DNA (cfDNA)产前筛查结果假阳性可能是由局限性胎盘嵌合体(CPM)引起的,尽管这种情况的频率和产科后果尚不清楚。目的:评估假阳性cfDNA结果中CPM的患病率以及相关的产科结局。研究设计:这是一项前瞻性匹配队列研究,cfDNA假阳性病例和低风险cfDNA对照组的比例为1:2,与母亲年龄和体重指数(BMI)相匹配。参与者于2022年11月至2025年3月在澳大利亚墨尔本的莫纳什健康和莫纳什妇女超声中心招募。对每个胎盘进行4次活检进行细胞遗传学检测以研究CPM。使用条件逻辑回归和线性混合效应模型,将病例和匹配对照进行随机效应的三人匹配标识符比较。结果:60例cfDNA假阳性与120例对照相匹配。60例患者中有20例(33.3%)出现CPM,对照组中无CPM。罕见常染色体三体(RAT)(57.9%, 11/19)和X单体(75.5%,3/4)中CPM患病率最高。在常见常染色体三体(21.4%,3/14)和亚染色体拷贝数变异(15.8%,3/19)结果中也观察到CPM。确诊CPM病例的出生体重百分位数中位数(20.1,四分位数间距(IQR) 9.9 - 48.5)显著低于匹配对照组(43.5,IQR 17.1 - 66.1, p = 0.049);然而,小胎龄新生儿或其他不良妊娠结局没有统计学上的显著增加。结论:CPM是导致cfDNA结果假阳性的常见因素,最常见的是X单体和RAT结果。虽然出生体重中位数较低,但在这个平均风险队列中,cfdna检测的CPM结果主要是有利的。
{"title":"Placental cytogenetic testing for confined placental mosaicism and obstetrical outcomes after discordant cell-free DNA screening results.","authors":"Yvette Raymond, Shavi Fernando, Melody Menezes, Ben W Mol, Emma Brown, Kirsten Arnold, Daniel L Rolnik","doi":"10.1016/j.ajogmf.2025.101887","DOIUrl":"10.1016/j.ajogmf.2025.101887","url":null,"abstract":"<p><strong>Background: </strong>A false-positive cell-free DNA prenatal screening result may arise from confined placental mosaicism, however, the frequency and obstetrical ramifications of such cases are poorly understood.</p><p><strong>Objective: </strong>This study aimed to assess the prevalence of confined placental mosaicism among pregnancies with false-positive cell-free DNA results and the associated obstetrical outcomes.</p><p><strong>Study design: </strong>This was a prospective, matched-cohort study with a 1:2 ratio of cases with false-positive cell-free DNA results and controls with low-risk cell-free DNA results that were matched by maternal age and body mass index. Participants were recruited between November 2022 and March 2025 at Monash Health and Monash Ultrasound for Women in Melbourne, Australia. Cytogenetic testing was conducted on 4 biopsies per placenta to investigate confined placental mosaicism. The cases and matched controls were compared using trio matching identifiers as random effect in conditional logistic regression and linear mixed-effects modelling.</p><p><strong>Results: </strong>A total of 60 cases with false-positive cell-free DNA results were matched with 120 controls. Confined placental mosaicism was observed in 20 of the 60 cases (33.3%) and in none of the controls. The prevalence of confined placental mosaicism was highest among those with rare autosomal trisomy (57.9%; 11/19) and monosomy X (75.5%; 3/4) results. Confined placental mosaicism was also observed following common autosomal trisomy results (21.4%; 3/14) and subchromosomal copy number variants (15.8%; 3/19). The median birth weight percentile was significantly lower among instances of confirmed confined placental mosaicism (20.1; interquartile range, 9.9-48.5) than among matched controls (43.5; interquartile range, 17.1-66.1; P=.049); however, there were no statistically significant increases in small-for-gestational-age neonates or other adverse pregnancy outcomes.</p><p><strong>Conclusion: </strong>Confined placental mosaicism is a frequent contributor to false-positive cell-free DNA results, most often for monosomy X and rare autosomal trisomy results. Although the birth weight median percentiles were lower, the outcomes of cell-free DNA-detected confined placental mosaicism in this average-risk cohort were predominantly favorable. VIDEO ABSTRACT.</p>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101887"},"PeriodicalIF":3.1,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continuous glucose monitoring in gestational diabetes mellitus: a tool, not a treatment 妊娠期糖尿病的持续血糖监测:一种工具,而不是治疗方法
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-07 DOI: 10.1016/j.ajogmf.2025.101877
Ashley N. Battarbee MD, MSCR
{"title":"Continuous glucose monitoring in gestational diabetes mellitus: a tool, not a treatment","authors":"Ashley N. Battarbee MD, MSCR","doi":"10.1016/j.ajogmf.2025.101877","DOIUrl":"10.1016/j.ajogmf.2025.101877","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 2","pages":"Article 101877"},"PeriodicalIF":3.1,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145926635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guideline gaps in emergency cerclage: evidence limitations and future directions. 紧急环切术的指南缺口:证据限制和未来方向。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-06 DOI: 10.1016/j.ajogmf.2025.101889
Aya Mudrik, Misgav Rottenstreich
{"title":"Guideline gaps in emergency cerclage: evidence limitations and future directions.","authors":"Aya Mudrik, Misgav Rottenstreich","doi":"10.1016/j.ajogmf.2025.101889","DOIUrl":"10.1016/j.ajogmf.2025.101889","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101889"},"PeriodicalIF":3.1,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antenatal corticosteroid use at 22 weeks: balancing guideline authority with evidence quality 22周产前皮质类固醇使用:平衡指南权威与证据质量
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101822
Can Ata MD, Ufuk Atlihan MD
{"title":"Antenatal corticosteroid use at 22 weeks: balancing guideline authority with evidence quality","authors":"Can Ata MD,&nbsp;Ufuk Atlihan MD","doi":"10.1016/j.ajogmf.2025.101822","DOIUrl":"10.1016/j.ajogmf.2025.101822","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101822"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underlying placental pathology lesions in pregnant individuals with diabetes and decreasing insulin requirements 潜在的胎盘病理病变妊娠个体糖尿病和降低胰岛素需求
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101826
Karen TY Wong MD MSc, Shane Khan MD, Alaa Husain MD, Asmaa Alahmadi MD, Youssef Nasr BSc, Dina El Demellawy MD, Ana Werlang MD
{"title":"Underlying placental pathology lesions in pregnant individuals with diabetes and decreasing insulin requirements","authors":"Karen TY Wong MD MSc,&nbsp;Shane Khan MD,&nbsp;Alaa Husain MD,&nbsp;Asmaa Alahmadi MD,&nbsp;Youssef Nasr BSc,&nbsp;Dina El Demellawy MD,&nbsp;Ana Werlang MD","doi":"10.1016/j.ajogmf.2025.101826","DOIUrl":"10.1016/j.ajogmf.2025.101826","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101826"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying the benefit of cerclage in singletons without prior spontaneous preterm birth already on vaginal progesterone 量化无自发性早产的单胎已服用阴道黄体酮的围扎术的益处
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101828
Vincenzo Berghella MD, Rupsa Boelig MD, Gabriele Saccone MD
{"title":"Quantifying the benefit of cerclage in singletons without prior spontaneous preterm birth already on vaginal progesterone","authors":"Vincenzo Berghella MD,&nbsp;Rupsa Boelig MD,&nbsp;Gabriele Saccone MD","doi":"10.1016/j.ajogmf.2025.101828","DOIUrl":"10.1016/j.ajogmf.2025.101828","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101828"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in academic research publishing: updates, controversies, and considerations for pregnancy and perinatal research 学术研究出版中的人工智能:妊娠和围产期研究的更新、争议和考虑。
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101885
Mariam Ayyash MD, MSCR , Amir Aviram MD , Nicole Krenitsky MD, MBA , Timothy Wen MD, MPH , Vincenzo Berghella MD
Artificial intelligence (AI) has rapidly transformed academic writing and publishing, progressing from simple grammar checkers and citation tools to sophisticated large language models capable of generating, synthesizing, and critically evaluating scientific content. A recent advancement in this space is the rise of deep research AI—agentic models that autonomously conduct structured reasoning to produce evidence-backed research outputs. While AI opens vast opportunities to enhance academic productivity, it also introduces significant ethical challenges. The challenge isn’t just to use AI; rather, to use it responsibly. As AI continues to reshape scholarly communication, it must be guided by clear oversight and ethical frameworks. This article explores AI’s expanding role in academic publishing, with a focus on its applications in manuscript preparation, peer review, and quality assessment. It also addresses the growing concerns surrounding authorship, research integrity, and accountability. We additionally outline key considerations unique to obstetrics and maternal–fetal medicine to guide responsible and field-appropriate AI use in perinatal research and publishing. Ultimately, the responsible integration of AI, balanced with human judgment and governed by rigorous standards, will be critical to ensuring both innovation and credibility in academic research.
人工智能(AI)已经迅速改变了学术写作和出版,从简单的语法检查和引用工具发展到能够生成、综合和批判性评估科学内容的复杂大型语言模型(llm)。这一领域的最新进展是深度研究人工智能的兴起——代理模型可以自主地进行结构化推理,以产生有证据支持的研究成果。虽然人工智能为提高学术生产力提供了巨大的机会,但它也带来了重大的伦理挑战。我们面临的挑战不仅仅是使用人工智能;而是负责任地使用它。随着人工智能继续重塑学术交流,它必须得到明确的监督和道德框架的指导。本文探讨了人工智能在学术出版中不断扩大的作用,重点介绍了人工智能在论文准备、同行评审和质量评估方面的应用。它还解决了围绕作者身份、研究诚信和问责制日益增长的担忧。我们还概述了产科和母胎医学特有的关键考虑因素,以指导围产期研究和出版中负责任和适合现场的人工智能使用。最终,人工智能的负责任整合,与人类的判断相平衡,并受到严格标准的约束,对于确保学术研究的创新和可信度至关重要。
{"title":"Artificial intelligence in academic research publishing: updates, controversies, and considerations for pregnancy and perinatal research","authors":"Mariam Ayyash MD, MSCR ,&nbsp;Amir Aviram MD ,&nbsp;Nicole Krenitsky MD, MBA ,&nbsp;Timothy Wen MD, MPH ,&nbsp;Vincenzo Berghella MD","doi":"10.1016/j.ajogmf.2025.101885","DOIUrl":"10.1016/j.ajogmf.2025.101885","url":null,"abstract":"<div><div>Artificial intelligence (AI) has rapidly transformed academic writing and publishing, progressing from simple grammar checkers and citation tools to sophisticated large language models capable of generating, synthesizing, and critically evaluating scientific content. A recent advancement in this space is the rise of deep research AI—agentic models that autonomously conduct structured reasoning to produce evidence-backed research outputs. While AI opens vast opportunities to enhance academic productivity, it also introduces significant ethical challenges. The challenge isn’t just to use AI; rather, to use it responsibly. As AI continues to reshape scholarly communication, it must be guided by clear oversight and ethical frameworks. This article explores AI’s expanding role in academic publishing, with a focus on its applications in manuscript preparation, peer review, and quality assessment. It also addresses the growing concerns surrounding authorship, research integrity, and accountability. We additionally outline key considerations unique to obstetrics and maternal–fetal medicine to guide responsible and field-appropriate AI use in perinatal research and publishing. Ultimately, the responsible integration of AI, balanced with human judgment and governed by rigorous standards, will be critical to ensuring both innovation and credibility in academic research.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 3","pages":"Article 101885"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145896711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to editor regarding “cerclage for short cervix ≤20 mm before 24 weeks in singleton gestations without prior spontaneous preterm birth decreases preterm birth: a meta-analysis of randomized controlled trials using individual patient-level data” 致编辑的关于“无自发性早产的单胎妊娠24周前短宫颈≤20mm环切术减少早产:使用个体患者水平数据的随机对照试验的荟萃分析”
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101827
Camille Blouin MD, Chantale Vachon-Marceau MD, Marie Haudiquet MD, Emmanuel Bujold MD MSc
{"title":"Letter to editor regarding “cerclage for short cervix ≤20 mm before 24 weeks in singleton gestations without prior spontaneous preterm birth decreases preterm birth: a meta-analysis of randomized controlled trials using individual patient-level data”","authors":"Camille Blouin MD,&nbsp;Chantale Vachon-Marceau MD,&nbsp;Marie Haudiquet MD,&nbsp;Emmanuel Bujold MD MSc","doi":"10.1016/j.ajogmf.2025.101827","DOIUrl":"10.1016/j.ajogmf.2025.101827","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101827"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to Editor regarding “Randomized, controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: The GUARDS trial” 关于“熊去氧胆酸对妊娠糖尿病患者血糖影响的随机对照试验:卫兵试验”的致编辑信
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101795
Huan Luo MD, Lei Pu PhD
{"title":"Letter to Editor regarding “Randomized, controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: The GUARDS trial”","authors":"Huan Luo MD,&nbsp;Lei Pu PhD","doi":"10.1016/j.ajogmf.2025.101795","DOIUrl":"10.1016/j.ajogmf.2025.101795","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101795"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' Reply re: Randomized, controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: the GUARDS trial 熊去氧胆酸对妊娠糖尿病患者血糖影响的随机对照试验:卫兵试验
IF 3.1 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.ajogmf.2025.101796
Catalina De Paco Matallana MD, Kypros H. Nicolaides MD, Catherine Williamson MD
{"title":"Authors' Reply re: Randomized, controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: the GUARDS trial","authors":"Catalina De Paco Matallana MD,&nbsp;Kypros H. Nicolaides MD,&nbsp;Catherine Williamson MD","doi":"10.1016/j.ajogmf.2025.101796","DOIUrl":"10.1016/j.ajogmf.2025.101796","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"8 1","pages":"Article 101796"},"PeriodicalIF":3.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Obstetrics & Gynecology Mfm
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1